Global OTC Drugs Market Report and Forecast to 2021

Published: Sep, 2017 | Pages: 165 | Publisher: 9Dimen Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

OTC Drugs Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).

In this report, the global OTC Drugs market is valued at USD XX million in 2017 and is projected to reach USD XX million by the end of 2021, growing at a CAGR of XX% during the period 2017 to 2021.

The report firstly introduced the OTC Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:

•	SK&F
•	CR Pharma
•	Pfizer
•	Bristol-Myers Squibb
•	Bayer
•	GlaxoSmithKline

The end users/applications and product categories analysis:

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-

•	Oral medical
•	Dietary supplements
•	Type C

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of OTC Drugs for each application, including-

•	Hospital
•	R&D
•	Home care

 Table of Contents 

Part I OTC Drugs Industry Overview 

Chapter One OTC Drugs Industry Overview 
1.1 OTC Drugs Definition 
1.2 OTC Drugs Classification Analysis 
Oral medical 
Dietary supplements 
Type C  
1.2.1 OTC Drugs Main Classification Analysis 
1.2.2 OTC Drugs Main Classification Share Analysis 
1.3 OTC Drugs Application Analysis 
Hospital 
R&D 
Home care  
1.3.1 OTC Drugs Main Application Analysis 
1.3.2 OTC Drugs Main Application Share Analysis 
1.4 OTC Drugs Industry Chain Structure Analysis 
1.5 OTC Drugs Industry Development Overview 
1.5.1 OTC Drugs Product History Development Overview 
1.5.1 OTC Drugs Product Market Development Overview 
1.6 OTC Drugs Global Market Comparison Analysis 
1.6.1 OTC Drugs Global Import Market Analysis 
1.6.2 OTC Drugs Global Export Market Analysis 
1.6.3 OTC Drugs Global Main Region Market Analysis 
1.6.4 OTC Drugs Global Market Comparison Analysis 
1.6.5 OTC Drugs Global Market Development Trend Analysis 

Chapter Two OTC Drugs Up and Down Stream Industry Analysis 
2.1 Upstream Raw Materials Analysis 
2.1.1 Upstream Raw Materials Price Analysis 
2.1.2 Upstream Raw Materials Market Analysis 
2.1.3 Upstream Raw Materials Market Trend 
2.2 Down Stream Market Analysis 
2.1.1 Down Stream Market Analysis 
2.2.2 Down Stream Demand Analysis 
2.2.3 Down Stream Market Trend Analysis 

Part II Asia OTC Drugs Industry (The Report Company Including the Below Listed But Not All) 
  
Chapter Three Asia OTC Drugs Market Analysis 
3.1 Asia OTC Drugs Product Development History 
3.2 Asia OTC Drugs Competitive Landscape Analysis 
3.3 Asia OTC Drugs Market Development Trend 

Chapter Four 2012-2017 Asia OTC Drugs Productions Supply Sales Demand Market Status and Forecast 
4.1 2012-2017 OTC Drugs Capacity Production Overview 
4.2 2012-2017 OTC Drugs Production Market Share Analysis 
4.3 2012-2017 OTC Drugs Demand Overview 
4.4 2012-2017 OTC Drugs Supply Demand and Shortage Analysis 
4.5 2012-2017 OTC Drugs Import Export Consumption Analysis 
4.6 2012-2017 OTC Drugs Cost Price Production Value Profit Analysis 

Chapter Five Asia OTC Drugs Key Manufacturers Analysis 
5.1 SK&F 
5.1.1 Company Profile 
5.1.2 Product Picture and Specification 
5.1.3 Product Application Analysis 
5.1.4 Capacity Production Price Cost Production Value Analysis 
5.1.5 Contact Information 
5.2 CR Pharma 
5.2.1 Company Profile 
5.2.2 Product Picture and Specification 
5.2.3 Product Application Analysis 
5.2.4 Capacity Production Price Cost Production Value Analysis 
5.2.5 Contact Information 
5.3 Company C 
5.3.1 Company Profile 
5.3.2 Product Picture and Specification 
5.3.3 Product Application Analysis 
5.3.4 Capacity Production Price Cost Production Value Analysis 
5.3.5 Contact Information 

Chapter Six Asia OTC Drugs Industry Development Trend 
6.1 2017-2021 OTC Drugs Capacity Production Trend 
6.2 2017-2021 OTC Drugs Production Market Share Analysis 
6.3 2017-2021 OTC Drugs Demand Trend 
6.4 2017-2021 OTC Drugs Supply Demand and Shortage Analysis 
6.5 2017-2021 OTC Drugs Import Export Consumption Analysis 
6.6 2017-2021 OTC Drugs Cost Price Production Value Profit Analysis 

Part III North American OTC Drugs Industry (The Report Company Including the Below Listed But Not All) 
  
Chapter Seven North American OTC Drugs Market Analysis 
7.1 North American OTC Drugs Product Development History 
7.2 North American OTC Drugs Competitive Landscape Analysis 
7.3 North American OTC Drugs Market Development Trend 

Chapter Eight 2012-2017 North American OTC Drugs Productions Supply Sales Demand Market Status and Forecast 
8.1 2012-2017 OTC Drugs Capacity Production Overview 
8.2 2012-2017 OTC Drugs Production Market Share Analysis 
8.3 2012-2017 OTC Drugs Demand Overview 
8.4 2012-2017 OTC Drugs Supply Demand and Shortage Analysis 
8.5 2012-2017 OTC Drugs Import Export Consumption Analysis 
8.6 2012-2017 OTC Drugs Cost Price Production Value Profit Analysis 

Chapter Nine North American OTC Drugs Key Manufacturers Analysis 
9.1 Pfizer 
9.1.1 Company Profile 
9.1.2 Product Picture and Specification 
9.1.3 Product Application Analysis 
9.1.4 Capacity Production Price Cost Production Value Analysis 
9.1.5 Contact Information 
9.1 Bristol-Myers Squibb 
9.2.1 Company Profile 
9.2.2 Product Picture and Specification 
9.2.3 Product Application Analysis 
9.2.4 Capacity Production Price Cost Production Value Analysis 
9.2.5 Contact Information 

Chapter Ten North American OTC Drugs Industry Development Trend 
10.1 2017-2021 OTC Drugs Capacity Production Trend 
10.2 2017-2021 OTC Drugs Production Market Share Analysis 
10.3 2017-2021 OTC Drugs Demand Trend 
10.4 2017-2021 OTC Drugs Supply Demand and Shortage Analysis 
10.5 2017-2021 OTC Drugs Import Export Consumption Analysis 
10.6 2017-2021 OTC Drugs Cost Price Production Value Profit Analysis 

Part IV Europe OTC Drugs Industry Analysis (The Report Company Including the Below Listed But Not All) 

Chapter Eleven Europe OTC Drugs Market Analysis 
11.1 Europe OTC Drugs Product Development History 
11.2 Europe OTC Drugs Competitive Landscape Analysis 
11.3 Europe OTC Drugs Market Development Trend 

Chapter Twelve 2012-2017 Europe OTC Drugs Productions Supply Sales Demand Market Status and Forecast 
12.1 2012-2017 OTC Drugs Capacity Production Overview 
12.2 2012-2017 OTC Drugs Production Market Share Analysis 
12.3 2012-2017 OTC Drugs Demand Overview 
12.4 2012-2017 OTC Drugs Supply Demand and Shortage Analysis 
12.5 2012-2017 OTC Drugs Import Export Consumption Analysis 
12.6 2012-2017 OTC Drugs Cost Price Production Value Profit Analysis 

Chapter Thirteen Europe OTC Drugs Key Manufacturers Analysis 
13.1 Bayer 
13.1.1 Company Profile 
13.1.2 Product Picture and Specification 
13.1.3 Product Application Analysis 
13.1.4 Capacity Production Price Cost Production Value Analysis 
13.1.5 Contact Information 
13.2 GlaxoSmithKline 
13.2.1 Company Profile 
13.2.2 Product Picture and Specification 
13.2.3 Product Application Analysis 
13.2.4 Capacity Production Price Cost Production Value Analysis 
13.2.5 Contact Information 

Chapter Fourteen Europe OTC Drugs Industry Development Trend 
14.1 2017-2021 OTC Drugs Capacity Production Trend 
14.2 2017-2021 OTC Drugs Production Market Share Analysis 
14.3 2017-2021 OTC Drugs Demand Trend 
14.4 2017-2021 OTC Drugs Supply Demand and Shortage Analysis 
14.5 2017-2021 OTC Drugs Import Export Consumption Analysis 
14.6 2017-2021 OTC Drugs Cost Price Production Value Profit Analysis 

Part V OTC Drugs Marketing Channels and Investment Feasibility 

Chapter Fifteen OTC Drugs Marketing Channels Development Proposals Analysis 
15.1 OTC Drugs Marketing Channels Status 
15.2 OTC Drugs Marketing Channels Characteristic 
15.3 OTC Drugs Marketing Channels Development Trend 
15.2 New Firms Enter Market Strategy 
15.3 New Project Investment Proposals 

Chapter Sixteen Development Environmental Analysis 
16.1 China Macroeconomic Environment Analysis 
16.2 European Economic Environmental Analysis 
16.3 United States Economic Environmental Analysis 
16.4 Japan Economic Environmental Analysis 
16.5 Global Economic Environmental Analysis 

Chapter Seventeen OTC Drugs New Project Investment Feasibility Analysis 
17.1 OTC Drugs Market Analysis 
17.2 OTC Drugs Project SWOT Analysis 
17.3 OTC Drugs New Project Investment Feasibility Analysis 

Part VI Global OTC Drugs Industry Conclusions 

Chapter Eighteen 2012-2017 Global OTC Drugs Productions Supply Sales Demand Market Status and Forecast 
18.1 2012-2017 OTC Drugs Capacity Production Overview 
18.2 2012-2017 OTC Drugs Production Market Share Analysis 
18.3 2012-2017 OTC Drugs Demand Overview 
18.4 2012-2017 OTC Drugs Supply Demand and Shortage Analysis 
18.5 2012-2017 OTC Drugs Cost Price Production Value Profit Analysis 

Chapter Nineteen Global OTC Drugs Industry Development Trend 
19.1 2017-2021 OTC Drugs Capacity Production Trend 
19.2 2017-2021 OTC Drugs Production Market Share Analysis 
19.3 2017-2021 OTC Drugs Demand Trend 
19.4 2017-2021 OTC Drugs Supply Demand and Shortage Analysis 
19.5 2017-2021 OTC Drugs Cost Price Production Value Profit Analysis 

Chapter Twenty Global OTC Drugs Industry Research Conclusions